These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 26908731)

  • 21. Quasispecies dynamics in main core epitopes of hepatitis B virus by ultra-deep-pyrosequencing.
    Homs M; Buti M; Tabernero D; Quer J; Sanchez A; Corral N; Esteban R; Rodriguez-Frias F
    World J Gastroenterol; 2012 Nov; 18(42):6096-105. PubMed ID: 23155338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.
    Weinberger KM; Bauer T; Böhm S; Jilg W
    J Gen Virol; 2000 May; 81(Pt 5):1165-74. PubMed ID: 10769057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.
    Martin CM; Welge JA; Shire NJ; Rouster SD; Shata MT; Sherman KE; Blackard JT
    J Viral Hepat; 2010 Aug; 17(8):588-97. PubMed ID: 19889143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult hepatitis B virus infection: influence of S protein variants.
    Zhang Z; Zhang L; Dai Y; Zhang Y; Li J; Li X
    Virol J; 2016 Jan; 13():10. PubMed ID: 26786229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity.
    Audsley J; Bent SJ; Littlejohn M; Avihingsanon A; Matthews G; Bowden S; Bayliss J; Luciani F; Yuen L; Fairley CK; Locarnini S; Lewin SR; Sasadeusz J
    AIDS; 2016 Jun; 30(10):1597-606. PubMed ID: 26950313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant.
    Xue Y; Wang MJ; Yang ZT; Yu DM; Han Y; Huang D; Zhang DH; Zhang XX
    Emerg Microbes Infect; 2017 Mar; 6(3):e15. PubMed ID: 28325923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients.
    Pollicino T; Isgrò G; Di Stefano R; Ferraro D; Maimone S; Brancatelli S; Squadrito G; Di Marco V; Craxì A; Raimondo G
    Antivir Ther; 2009; 14(5):649-54. PubMed ID: 19704167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.
    Fernández-Galindo DA; Sánchez-Ávila F; Bobadilla-Morales L; Gómez-Quiróz P; Bueno-Topete M; Armendáriz-Borunda J; Sánchez-Orozco LV
    J Med Virol; 2015 Jun; 87(6):985-92. PubMed ID: 25732900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing.
    Wang Y; Xiao X; Chen S; Huang C; Zhou J; Dai E; Li Y; Liu L; Huang X; Gao Z; Wu C; Fang M; Gao C
    Front Immunol; 2021; 12():775461. PubMed ID: 34899733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variability in coding regions of the surface antigen and reverse transcriptase domain of hepatitis B virus polymerase, Colombia, 2002-2014.
    Peláez-Carvajal D; Forero NJ; Escalante-Mora M; Laiton-Donato K; Usme-Ciro JA
    Biomedica; 2018 Aug; 38(0):37-50. PubMed ID: 30184362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.
    Wu C; Zhang X; Tian Y; Song J; Yang D; Roggendorf M; Lu M; Chen X
    J Gen Virol; 2010 Feb; 91(Pt 2):483-92. PubMed ID: 19812261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different Variants in Reverse Transcriptase Domain Determined by Ultra-deep Sequencing in Treatment-naïve and Treated Indonesian Patients Infected with Hepatitis B Virus.
    Wasityastuti W; Yano Y; Widasari DI; Yamani LN; Ratnasari N; Heriyanto DS; Okada R; Tanahashi T; Murakami Y; Azuma T; Hayashi Y
    Kobe J Med Sci; 2016 Jun; 62(1):E1-8. PubMed ID: 27492206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.
    Coppola N; Tonziello G; Colombatto P; Pisaturo M; Messina V; Moriconi F; Alessio L; Sagnelli C; Cavallone D; Brunetto M; Sagnelli E
    J Infect; 2013 Oct; 67(4):322-8. PubMed ID: 23796869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enrichment of HBV immune-escape mutations during nucleoside/nucleotide analogue therapy.
    Shan M; Shen Z; Sun H; Zheng J; Zhang M
    Antivir Ther; 2017; 22(8):717-720. PubMed ID: 28300730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay.
    Gencay M; Vermeulen M; Neofytos D; Westergaard G; Pabinger S; Kriegner A; Seffner A; Gohl P; Huebner K; Nauck M; Kaminski WE
    J Clin Virol; 2018 Apr; 101():38-43. PubMed ID: 29414186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants.
    Sticchi L; Caligiuri P; Cacciani R; Alicino C; Bruzzone B
    Hum Vaccin Immunother; 2013 Mar; 9(3):568-71. PubMed ID: 23296324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early changes in quasispecies variant after antiviral therapy for chronic hepatitis B.
    Liang Y; Yano Y; Putri WA; Mardian Y; Okada R; Tanahashi T; Murakami Y; Hayashi Y
    Mol Med Rep; 2018 Apr; 17(4):5528-5537. PubMed ID: 29393485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute hepatitis B due to immune-escape mutations in a naturally immune patient.
    Kaymakoglu S; Baran B; Onel D; Badur S; Atamer T; Akyuz F
    Acta Gastroenterol Belg; 2014 Jun; 77(2):262-5. PubMed ID: 25090827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus.
    Torresi J
    J Clin Virol; 2002 Aug; 25(2):97-106. PubMed ID: 12367644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.